February 19, 2018
From the Blog
Bringing Rare Disease to the Forefront
February 26, 2021
Heart Disease & COVID-19 Are a Dangerous Mix for EU Patients
February 12, 2021
February 19, 2018
Nordic Patient Groups Tackle Biosimilar Policy Issues
October 13, 2016
GAfPA Asks: What are the Critical International Barriers to Patient Access?
August 25, 2016
Global Poster Presentations Convey Need for Distinct Biosimilar Names
July 5, 2016
Differences in Physicians Understanding of Biologics and Biosimilars in the U.S. and Europe
June 23, 2016
Barcelona Report Released: Biologics and Biosimilars Advocacy Workshop of Patient Safety
June 20, 2016
NORSWITCH Meeting Invites Dialogue on Biosimilar Switching
June 15, 2016
Sign up to receive updates from GAfPA
Bringing Rare Disease to the Forefront
February 26, 2021
Heart Disease & COVID-19 Are a Dangerous Mix for EU Patients
February 12, 2021